Abstract
In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Letters in Organic Chemistry
Title: A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice
Volume: 8 Issue: 8
Author(s): G. S. Paiva, Carlton A. Taft and Ivone A. de Souza
Affiliation:
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Abstract: In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Export Options
About this article
Cite this article as:
S. Paiva G., A. Taft Carlton and A. de Souza Ivone, A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice, Letters in Organic Chemistry 2011; 8 (8) . https://dx.doi.org/10.2174/157017811797249407
DOI https://dx.doi.org/10.2174/157017811797249407 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Designing HIV Integrase Inhibitors-Shooting the Last Arrow
Current Medicinal Chemistry Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Current Drug Targets CD40L - A Multipotent Molecule for Tumor Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles
Current Pharmaceutical Design Anti-MDR Effects of Quercetin and its Nanoemulsion in Multidrug-Resistant Human Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
Current Medicinal Chemistry The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets DNA Vaccines for Prostate Cancer
Current Cancer Therapy Reviews GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Editorial [Hot topic: Bisphosphonates and Bone Diseases: Past, Present and Future (Guest Editor: Dominique HEYMANN)]
Current Pharmaceutical Design Antibody-Drug Conjugate Targets
Current Cancer Drug Targets The Endothelial-Mesenchymal Transition (EndMT) and Tissue Regeneration
Current Stem Cell Research & Therapy Kidney Diseases and Chemokines
Current Drug Targets New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design